Ichthyosis Tied to Increased Risk of Depression, Anxiety
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, Dec. 1, 2023 -- Ichthyosis is associated with increased likelihood of depression and anxiety, according to a research letter published online Oct. 18 in the Journal of the American Academy of Dermatology.
Gloria Chen, from the Yale School of Medicine in New Haven, Connecticut, and colleagues investigated the relationship between ichthyosis and clinical diagnoses of depression and anxiety. Analysis included 334 congenital ichthyosis cases and 1,336 matched controls identified through the All of Us Research Program.
The researchers found that individuals with ichthyosis were more likely to have diagnoses of depression (41.9 versus 23.8 percent) and anxiety (15.9 versus 7.0 percent) than matched controls. When adjusting for smoking status and hypothyroidism, ichthyosis was significantly associated with depression (odds ratio, 2.33) and anxiety (odds ratio, 2.48).
"Our findings of increased risk of depression and anxiety in individuals with ichthyosis highlight the need for routine quality of life and mental health assessments in this population as a standard of care," the authors write. "Attention to this important aspect of these disorders is essential for optimal care of the entire patient."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-02 00:34
Read more
- Gestational Exposure to NSAIDs Tied to Childhood Chronic Kidney Disease
- Prevalence of Infant Nonsupine Sleep Position Steady From 2016 to 2022
- FDA Says Shortage of GLP-1 Tirzepatide (Mounjaro, Zepbound) Is Over
- Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
- Pain Coping Skills Training Beneficial During Maintenance Hemodialysis
- Patient Care Experience Worse After Private Equity Acquisition of Hospitals
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions